|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Institute of Biochemistry and Medical Chemistry (G.V., A.T., Z.B., B.V., B.S.), Department of Cardiology (A.T.), Medical School, University of Pecs, Pecs, Hungary; Hungarian Academy of Sciences (B.S.), Research Group for Mitochondrial Function and Mitochondrial Diseases, Budapest, Hungary; and Department of Anatomy (F.G.), School of Medical Sciences, University of Bristol, Bristol, United Kingdom
Amiodarone is a widely used and potent antiarrhythmic agent that is metabolized to desethylamiodarone. Both amiodarone and its metabolite possess antiarrhythmic effect, and both compounds can contribute to toxic side effects. Here, we compare the effect of amiodarone and desethylamiodarone on mitochondrial energy metabolism, membrane potential, and permeability transition and on mitochondria-related apoptotic events. Amiodarone but not desethylamiodarone protects the mitochondrial energy metabolism of the perfused heart during ischemia in perfused hearts. At low concentrations, amiodarone stimulated state 4 respiration due to an uncoupling effect, inhibited the Ca2+-induced mitochondrial swelling, whereas it dissipated the mitochondrial membrane potential (
), and prevented the ischemia-reperfusion-induced release of apoptosis-inducing factor (AIF). At higher concentrations, amiodarone inhibited the mitochondrial respiration and simulated a cyclosporin A (CsA)-independent mitochondrial swelling. In contrast to these, desethylamiodarone did not stimulate state 4 respiration, did not inhibit the Ca2+-induced mitochondrial permeability transition, did not induce the collapse of 
in low concentrations, and did not prevent the nuclear translocation of AIF in perfused rat hearts, but it induced a CsA-independent mitochondrial swelling at higher concentration, like amiodarone. That is, desethylamiodarone lacks the protective effect of amiodarone seen at low concentrations, such as the inhibition of calcium-induced mitochondrial permeability transition and inhibition of the nuclear translocation of the proapoptotic AIF. On the other hand, both amiodarone and desethylamiodarone at higher concentration induced a CsA-independent mitochondrial swelling, resulting in apoptotic death that explains their extracardiac toxic effect.
Address correspondence to: Dr. Balazs Sumegi, Institute of Biochemistry and Medical Chemistry, Medical School, University of Pecs, 12 Szigeti St., H-7624 Pecs, Hungary. E-mail: balazs.sumegi{at}aok.pte.hu
This article has been cited by other articles:
![]() |
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sanoudou, E. Vafiadaki, D. A. Arvanitis, E. Kranias, and A. Kontrogianni-Konstantopoulos Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies Physiol Genomics, April 14, 2005; 21(2): 131 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chen, Z. Zsengeller, C.-Y. Xiao, and C. Szabo Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1 Cardiovasc Res, September 1, 2004; 63(4): 682 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Xiao, M. Chen, Z. Zsengeller, and C. Szabo Poly(ADP-Ribose) Polymerase Contributes to the Development of Myocardial Infarction in Diabetic Rats and Regulates the Nuclear Translocation of Apoptosis-Inducing Factor J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 498 - 504. [Abstract] [Full Text] [PDF] |
||||